Unknown

Dataset Information

0

The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/?-catenin signaling in human multiple myeloma.


ABSTRACT: Deregulated iron metabolism underlies the pathogenesis of many human cancers. Recently, low expression of ferroportin, which is the only identified non-heme iron exporter, has been associated with significantly reduced overall survival in multiple myeloma (MM); however, the altered iron metabolism in MM biology remains unclear. In this study we demonstrated, by live cell imaging, that MM cells have increased intracellular iron levels as compared with normal cells. In experiments to test the effect of iron chelation on the growth of MM cells, we found that deferasirox (DFX), an oral iron chelator used to treat iron overload in clinical practice, inhibits MM cell growth both in vivo and in vitro. Mechanistically, DFX was found to induce apoptosis of MM cells via the inhibition of proline-rich tyrosine kinase 2 (Pyk2), which is known to promote tumor growth in MM. Inhibition of Pyk2 is caused by the suppression of reactive oxygen species, and leads to downregulation of the Wnt/?-catenin signaling pathway. Taken together, our findings indicate that high levels of intracellular iron, which might be due to low ferroportin expression, play a role in MM pathophysiology. Therefore, DFX may provide a therapeutic option for MM that is driven by deregulated iron homeostasis and/or Pyk2/Wnt signaling.

SUBMITTER: Kamihara Y 

PROVIDER: S-EPMC5325446 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma.

Kamihara Yusuke Y   Takada Kohichi K   Sato Tsutomu T   Kawano Yutaka Y   Murase Kazuyuki K   Arihara Yohei Y   Kikuchi Shohei S   Hayasaka Naotaka N   Usami Makoto M   Iyama Satoshi S   Miyanishi Koji K   Sato Yasushi Y   Kobune Masayoshi M   Kato Junji J  

Oncotarget 20160901 39


Deregulated iron metabolism underlies the pathogenesis of many human cancers. Recently, low expression of ferroportin, which is the only identified non-heme iron exporter, has been associated with significantly reduced overall survival in multiple myeloma (MM); however, the altered iron metabolism in MM biology remains unclear. In this study we demonstrated, by live cell imaging, that MM cells have increased intracellular iron levels as compared with normal cells. In experiments to test the effe  ...[more]

Similar Datasets

| S-EPMC6132348 | biostudies-literature
2024-09-27 | GSE274956 | GEO
| S-EPMC6437492 | biostudies-literature
| S-EPMC5557045 | biostudies-literature
| S-EPMC6994599 | biostudies-literature
| S-EPMC8361985 | biostudies-literature
2022-11-16 | GSE218133 | GEO
2018-12-04 | GSE123277 | GEO
| S-EPMC5906147 | biostudies-literature
2018-10-05 | PXD006051 | Pride